|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/17 | |||
| C12P 21/08 | |||
| A61K 39/00 | |||
| C07K 16/18 |
| (11) | Patento numeris | 2450056 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11175183.0 |
| Europos patento paraiškos padavimo data | 2006-07-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-05-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 185907 | 2005-07-19 | US | |
| PCT/US2005/0281 | 2005-08-09 | WO |
| (72) |
Schenk, Dale B., US
Masliah, Eliezer, US
Buttini, Manuel J., US
Chilcote, Tamie J., US
Rockenstein, Edward, US
Games, Dora Kate, US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
Prothena Biosciences Limited, Adelphi Plaza Upper George`s Street D n Laoghaire, Co. Dublin, A96 T927, IE |
| (54) | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| Prevention and treatment of synucleinopathic and amyloidogenic disease |